New Saliva Test Diagnoses Endometriosis in Days, Not Years

For years, Ami Robertson was told her excruciating pain was just irritable bowel syndrome. At 23, she finally got a diagnosis that changed her life in less than an hour.

The UK's National Health Service just approved two revolutionary tests that can detect endometriosis without surgery. The Endotest analyzes saliva for tiny biological markers, while EndoSure measures electrical signals in the gut using sensor pads on the abdomen.

These tests replace the traditional diagnosis method: a surgical procedure requiring general anesthesia and a camera inserted through the abdomen. That invasive approach contributed to an average nine-year wait for women seeking answers.

Endometriosis affects one in ten women of reproductive age in the UK. The painful condition causes cells similar to those in the womb to grow in other parts of the body, leading to severe pelvic pain, heavy bleeding, and difficulty getting pregnant.

Fifteen-year-old Simran Chavda suffered for two years before the EndoSure test revealed widespread endometriosis. "Getting my diagnosis honestly felt like the best thing in the world," she said. "The test itself was easy, it wasn't painful at all. Really simple."

For Ami, the Pilates instructor from Glasgow, the quick diagnosis meant finally being believed. "I spent years being told my pain was something else entirely. I started to doubt myself, wondering if it was all in my head," she shared. "Today my quality of life is night and day compared to before."

Dr. Gail Busby, a gynecologist at Manchester University NHS Foundation Trust, calls the advancement "a game-changer." Earlier diagnosis means women can start treatment sooner, and hospitals can free up surgical slots for other patients waiting for care.

The Ripple Effect

Beyond individual relief, these tests transform the entire healthcare system's approach to women's pain. Younger patients like Simran are getting diagnosed before the condition progresses to require extensive surgery.

The NHS is funding both tests while researchers collect more data on their success rates. The Endotest results come from a laboratory within days, while EndoSure delivers answers in just 45 minutes.

Dr. Anastasia Chalkidou emphasizes the life-changing impact: "That delay means living with chronic pelvic pain. These technologies have the potential to change that by allowing earlier and better treatment quickly."

Ebony Dowdell, who endured periods lasting four months over eight years before her diagnosis, believes faster testing would have prevented her condition from advancing to the point of needing robotic surgery. "Having a diagnosis makes you feel human, you know it is not in my head and you are not crazy," the 20-year-old said.

Thousands of women across the UK can now access answers without years of suffering and self-doubt.